Form D · Other Health Care
Avisi Technologies, Inc.
Philadelphia, PA · CIK 0001952426
Offering snapshot reported Nov 21, 2022 · SEC filing
- Reported sold
- $5.34M Indefinite offering
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 21, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 21, 2022 | Initial | $5,339,168 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-465397
Series Seed Preferred Stock
Source: Form D, filed Nov 21, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rui Jing Jiang | Director, Executive |
| Brandon Kao | Director |
| Catherine Mohr | Director |
| Paul Norris | Director |
| Gary Pruden | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3401 Grays Ferry Ave, Bldg 450
Philadelphia, PA, 19146
Philadelphia, PA, 19146